BioSpace News Archive

XCR Diagnostics announced today that it has appointed Chuck Morrison, a seasoned medical diagnostics expert, to its Board of Directors.

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps, founder, chairman, president and CEO, and Peter Kuipers, executive vice president and CFO, will be presenting at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, CA.

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases, asthma and allergic diseases, today announced the appointment of Allen Yang, M.D., Ph.D., as senior vice president and chief medical officer.

Fluidigm Corporation (NASDAQ:FLDM), announced today that The University of Michigan Protein Assembly Lab, a hub for collaborative and innovative research at the intersection of synthetic biology, protein engineering and personalized medicine,

Surescripts Network Alliance™ Prepares to Implement NCPDP SCRIPT Version 2017071 E-Prescribing Standard for Improved Prescription Accuracy, Patient Safety and Workflow Efficiency

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it has entered into a one-year agreement with Al Danah Medical Company (“Al Danah”) for distribution of the Obalon Navigation Balloon System in Qatar.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Royalty Pharma today announced that Ultragenyx has sold to Royalty Pharma for $320 million a royalty right due to Ultragenyx from Kyowa Kirin Co., Ltd for the net sales of Crysvita® (burosumab) in the European Union (EU), the United Kingdom (UK), and Switzerland.

TheraLight’s award-winning and innovative full-body photobiomodulation system nominated, and finalists to be announced in February

Pfizer Inc. (NYSE: PFE) and Mylan N.V. (NASDAQ: MYL) today announced that Ian Read and James Kilts will join the Viatris board of directors upon completion of the planned combination of Mylan N.V. and Upjohn Inc., which is expected to occur in mid-2020.

Zoetis Inc. (NYSE:ZTS) will participate in the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2020, in San Francisco, Calif. Kristin Peck, who will become Chief Executive Officer of Zoetis on January 1, 2020, will represent the company and respond to questions from analysts.